Industry Information

Update August 16, 2021

Pfizer and Moderna have been approved for enhanced injections. What is the protection of the new crown vaccine?

The global COVID-19 pandemic has returned, and the pandemic alert has once again made all countries suffer. Even China, which has been quiet for a long time, has had small-scale outbreaks in the face...

Update August 13, 2021

Top 20 multinational pharmaceutical companies in revenue! AbbVie's volume soars, Regeneron has the fastest growth rate, and Pfizer is back to number one

It has been more than a month since the multinational pharmaceutical companies began to publish their semi-annual reports. With the recent announcement of the semi-annual reports of Novo Nordisk,...

Update August 12, 2021

CAR-T therapy ushered in a harvest period, how to break through the safety bottleneck?

Recently, Yaozhi data shows that the listing application of WuXi's Noreki Orencel injection (relma-cel) has entered the "pending approval" status, and it is expected to be approved as the second...

Update August 11, 2021

The collection of proprietary Chinese medicines is coming! 10 varieties are most likely to enter, and 20+ companies will be affected...the list is attached!

On August 9, the National Medical Insurance Administration issued the "Response of the National Medical Insurance Administration to Recommendation No. 4126 of the Fourth Session of the Thirteenth...

Update August 10, 2021

Sanofi continues to increase mRNA vaccines, can it achieve overtaking in corners?

Recently, Sanofi announced that it has reached a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutic drug company. Sanofi will acquire all issued shares of Translate Bio for...

Update August 06, 2021

After many months of hard work, the big medical market after the epidemic rebounded is once again a "short-lived"

On August 3, the three major A-share indexes opened lower across the board in the morning trading, and the fluctuations continued during the period. Previously, many popular curtain stocks such as...

Update August 05, 2021

43 varieties have been reviewed! 10 varieties were the first to be reviewed, Chengdu Better took the lead, Tianjin Hongri, Yichang Renfu...

According to the consistency evaluation analysis system of Yaozhi Data Enterprise Edition, 80 new consistency evaluation acceptance numbers were added in July 2021; 58 approvals (including 22 deemed...

Update August 04, 2021

The second domestic cell therapy will be launched soon. Is CAR-T a good business?

On July 30, the listing application for the CAR-T product, relma-cel, of WuXi Giant Nuo targeting CD19, has been completed on-site inspection and is waiting for approval. Following the launch of...

Update August 03, 2021

Three Chinese pharmaceutical companies are among the Fortune Global 500 in 2021! China Resources, Sinopharm, Guangzhou Pharmaceutical

Today (August 2nd), Fortune PlusAPP released the latest Fortune Global 500 list simultaneously with the world. Affected by the new crown epidemic, the operating income of the Fortune Global 500...

Update August 02, 2021

Half-year transcripts of 10 multinational pharmaceutical companies: led by Johnson & Johnson, Roche's new drugs are in force, Pfizer's new crown vaccine sold 11.3 billion US dollars, Novartis, BMS, Gilead...

Since July, according to incomplete statistics from Yaozhi.com, as of July 30, 10 companies including Johnson & Johnson, Pfizer, Roche, Novartis, and BMS have successively announced mid-year...